In this primer on bipolar disorder, learn about the types, burden, pathophysiology, and symptoms of the disorder as well as psychiatric comorbidities, treatment guidelines, and nonpharmacological management.
Two advisory committees appointed by the US Food and Drug Administration (FDA) have voted in favor of ALKS 3831, a combination of olanzapine and the novel molecular entity samidorphan, Alkermes announced.
When used as adjunctive therapy with the mood stabilizers lithium or valproate, the schizophrenia drug lumateperone 42 mg improved depressive symptoms in patients with bipolar depression experiencing major depressive episodes, Intra-Cellular…
Although a quarter of patients presenting with depressive symptoms in primary care have bipolar disorder, a misdiagnosis of major depressive disorder is common, according to a poster presented at Psych Congress 2020.
Despite guidelines against their use as first-line therapy for bipolar disorder, antidepressants were frequently prescribed to patients for initial treatment, according to an analysis presented at Psych Congress 2020.